About the ELEVATE UC Trials
The ELEVATE UC program consists of two worldwide clinical trials and an open-label extension study to test how an oral investigational medication (etrasimod) works in patients with UC.
We’re looking for participants to take part in this important research, intended to improve UC symptoms and treatment. Participants will be treated by GI specialists at centers worldwide.
The investigational medication being studied in the
ELEVATE UC trials is a pill, taken orally once per day.